Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Dermatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Tralokinumab – Updates in Atopic Dermatitis
7
Mins
May 2025
Atopic dermatitis (AD) is a chronic, relapsing, inflammatory skin condition, associated with a high disease burden that affects patients…
Read more
7
Mins
29 May 2025
Tralokinumab – Updates in Atopic Dermatitis
Atopic dermatitis (AD) is a chronic, relapsing, inflammatory skin condition, associated with a high disease burden that affects patients…
3
Mins
11 Mar 2025
Nemolizumab in Atopic Dermatitis
Nemolizumab is an anti-IL-31Rα monoclonal antibody that has demonstrated clinical efficacy in two global Phase III studies (ARCADIA-1 and…
9
Mins
7 Nov 2024
Epigenetics to Reverse Skin Ageing
Epigenetic changes drive skin aging by silencing the expression of youthful genes. Experts discussed the discovery of epicelline, an…
11
Mins
7 Nov 2024
Vitiligo, Beyond White Patches
A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis and…
6
Mins
7 Nov 2024
Mechanisms of Response to Bimekizumab for Psoriatic Disease
Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based on…
7
Mins
23 Nov 2023
Bimekizumab 3-Year Efficacy in Patients with Moderate-to-Severe Plaque Psoriasis: Response Maintenance, Re-treatment, and Effect on High-Impact Areas
Psoriasis symptoms can be not only uncomfortable, irritating, and painful, but can also impact several aspects of a patients’ daily life…
8
Mins
23 Nov 2023
Secukinumab for Patients with Moderate-to-Severe Hidradenitis Suppurativa: Post Hoc Analyses of Efficacy Endpoints, Draining Tunnels, Skin Pain, and Work Productivity
Due to the clinical heterogenicity of HS, assessment of disease severity is complex, and over 20 different outcome measures have…
2
Mins
23 Nov 2023
Efficacy and Safety of Upadacitinib in a Phase II Randomised, Double-Blind, Dose-Ranging Study of Adults with Extensive Non-segmental Vitiligo
Vitiligo is an autoimmune skin disorder that causes depigmentation of the skin and/or leukotrichia of the hair, resulting from the…
Loading posts...
1
2
3
…
11
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View